RESEARCH LIBRARY

Evidence deserves context.

Original publications, clearly identified test materials and the limits of what each study can tell us.

3 publications

Human study · related ingredient

S-equol: identify the tested material.

A randomized trial studied an S-equol supplement in 160 postmenopausal Japanese women over 12 weeks. The test material was SE5-OH, not FemKudzu.

Aso et al. · Journal of Women’s Health · 2012

Interpretation: this publication provides related-ingredient context. It does not establish equivalence to fermented kudzu powder or validate a FemKudzu dosage.

Read the source

FemKudzu →

Human study · related ingredient

LBP and LbGp: names need context.

This publication reports an interim analysis of a six-week trial in 29 adolescents. It describes the test material as Lycium barbarum polysaccharide (LBP).

Li et al. · Neural Regeneration Research · 2022

Interpretation: the name LBP does not establish that the material is the current Dr. LbGp ingredient. This citation is not a product efficacy or treatment claim.

Read the source

Dr. LbGp →

Laboratory & animal study

Spore polysaccharides: structure comes first.

This study examines the structure and in vivo activity of isolated Ganoderma spore polysaccharides. The studied fractions are specific research materials.

Molecules · 2024 · 29(10), 2348

Interpretation: structural and animal findings do not establish human efficacy or equivalence to the current commercial GSP ingredient.

Read the source

GSP →

How to use this libraryThis is a selected reading list, not a systematic review. A related-ingredient publication is not a clinical endorsement of a Geliita product. Review the full paper, study population, test material, dose, duration and limitations before making a development decision. Study doses are not product-use instructions.

Content reviewed: 6 November 2026

Let’s develop what comes next.

Tell us about your formulation, your market and the ingredient you want to explore.

Start a conversation